Industry Reports

Sanofi India Limited (SANOFI) - Financial and Strategic SWOT Analysis Review

Friday, Apr 15, 2016

Sanofi India Limited (Sanofi India), a subsidiary of Sanofi is a pharmaceutical company that manufactures medicines for the treatment of patients in several therapeutic areas. Its product portfolio includes ramipril, amlodipine, hydrochlorothiazide, frusemide, spironolactone, frusemide, piperacillin, tazobactam, cefpirome sulphate, meropenem, gemifloxacin, azithromycin, ofloxacin, levofloxacin, rabeprazole, domperidone and others. Sanofi India’s target therapy areas include cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective diseases, orthopedic diseases, gastrointestinal disorders, and central nervous system. The company was formerly known as Aventis Pharma Limited. It has two state-of-the-art manufacturing facilities at Ankleshwar, Gujarat and Verna, Goa. Sanofi India is headquartered in Mumbai, Maharashtra, India.

Read More>